Triple-Negative Breast Cancer (TNBC) Active Not Recruiting Phase 1 Trials for Cabozantinib (DB08875)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02071862Study of the Glutaminase Inhibitor CB-839 in Solid TumorsTreatment